SlideShare a Scribd company logo
Dr.Nidhi Ahya
Assistant Professor
Cardio-Vascular & Respiratory PTDVVPF
College of Physiotherapy,
Ahmednagar 414111
Definition
Purpose
Indications & contra-indication
 lung volumes & capacities
Flow – volume curve
Classification : obstructive & restrictive
Clinical interpretation.
Pulmonary function testing is the process of
having the patient perform specific inspiratory
and expiratory maneuvers while breathing in and
out of tubing attached to the equipment that
measure a variety of variables
To determine the functional status of the
lungs
How much gas can be moved in and out of the lungs
How fast gas can be moved
The stiffness of the lung and chest wall
The diffusion characteristics of the alveolar-capillary
membrane
How well lung responds to the therapy
Pulmonary function testing
• To evaluate symptoms, signs or abnormal
laboratory tests
• To measure the effect of disease on pulmonary
function
• To differentiate between obstructive and
restrictive disease
• To screen individuals at risk of having pulmonary
disease
• To assess pre-operative risk
• To assess prognosis, response to therapy
• Hemoptysis of unknown origin
• Pneumothorax
• Unstable cardiovascular status or recent MI or
pulmonary embolus
• Thoracic, abdominal or cerebral aneurysms
• Presence of an acute disease process that might
interfere with test performance
• Recent surgery of thorax and abdomen
Nosocomial infection contracted from improperly
cleaned tubing, mouthpiece
 Height and weight:
Taller person, larger lung size, and larger predicted
lung volume
Muscular person-increase in lung size
Obese person-reduction in lung size
 Gender: Males>females
 Age:
Vital capacity increases in person until mid 20s
Average predicted VC for 20yrs is slightly over 5lt
By age 70, approx 4lt
Race
Environmental factors
Personal Factors
Pulmonary function testing
Volume of air exhaled and inhaled during quiet
breathing
350-600ml
Decrease Vt can occur both in restrictive an
obstructive defects
The inspiratory reserve volume is the extra volume
of air that can be inspired over and above the normal
tidal volume when the person inspires forcefully.
 It is usually equal to about 3000 ml
The expiratory reserve volume is the maximum
extra volume of air that can be expired by forceful
expiration after the end of a normal tidal expiration
 It normally amounts to about 1100 ml
The residual volume is the volume of air remaining in
the lungs after the most forceful expiration
 This volume averages about 1200 Ml
Is reduced in restrictive defects
Increased in obstructive defects
Expressed as ratio to TLC and VC
Pulmonary function testing
Pulmonary function testing
The inspiratory capacity equals the tidal volume
plus the inspiratory reserve volume.
It’s the amount of air a person can breathe in,
beginning at the normal expiratory level and
distending the lungs to the maximum amount.
about 3500 milliliters
 The vital capacity equals the inspiratory reserve
volume plus the tidal volume plus the expiratory
reserve volume.
This is the maximum amount of air a person can
expel from the lungs after first filling the lungs to
their maximum extent and then expiring to the
maximum extent
About 4600 ml
If the person forcefully exhales the volume, it is
called Forced vital capacity(FVC)
Three phases of FVC maneuver:
Maximal inspiratory effort
Initial expiratory blast
Forceful emptying of the lungs
Both restrictive and obstructive defects can cause
decrease in VC
Important preoperative assessment factor useful in
evaluating the patient’s need for mechanical
ventilation
FRC = ERV+RV
Resting volume of the lungs after exhalation of Vt
breath
This is the amount of air that remains in the lungs at
the end of normal expiration
About 2300 ml
Represents balance between the expanding chest
wall forces and the contractile rebound forces of
lung tissue
Sum of VC and RV
Is increased with most obstructive lung defects and
decreased with restrictive lung defects
To measure TLC, RV must be determined
The lung volumes that can be directly measured
using a spirometer include- Tidal Volume, Inspiratory
Reserve Volume, Expiratory Reserve Volume and
thus Vital Capacity
Total Lung Capacity can be measured if RV and
FRC are known.
RV and FRC is obtained in one of indirect methods:
Body plethysmograph (body box)
Open-circuit nitrogen washout
Closed-circuit helium dilution
Generated by integrating
flow with volume on graph
Volume is plotted on the
horizontal axis
Flow on the vertical axis
Expiratory loop is shown
above the line
Generated by
integrating volume
with time on graph
Volume is plotted on
the vertical axis
Time on the
horizontal axis
Volume – Liters
Time- secs
The expiratory side of the FVC curve provides data
regarding the contractile state of the airways
This part of the curve evaluates the amount of the
obstruction present in the patient’s airways
Routinely identified flows are:
FEV1 --FEV25%-75%
FEV3 --PEF
Measures the maximal volume of air exhaled during
the first second of expiration
Reflects the flow characteristics in the larger airways
Best indicator of obstructive diseases
Expressed as percentage of the observed FVC
(FEV1/FVC)
Normal: 75% of VC in 1 second
Decreased: acute and chronic obstructive pulmonary
disease
Normal in restrictive disorders
Look at the 3-second point of the expired curve
Indication of the flow in smaller airways
Decrease normally with age
Normal: approx 95%
FEV25%-75%
Expressed in liters/second
Indicator of flow
First 25% is disregarded because of the lung’s initial
inertia
Last 25% is disregarded because of effort
dependency
Middle 50% reflects the degree of airway patency
Early indicator of obstructive disease
Can also be reduced in restrictive dysfunction
Is the maximum flow rate achieved by the patient
during the FVC maneuver
PEF < 100L/min : severe obstructive disease
PEF= 100 to 200L/min : moderate obstructive
disease
PEF > 200L/min : mild obstructive disease
Indicates the respiratory muscle endurance
Requires the patient to inhale and exhale as quickly
as possible for a period of 12 secs
Normal: 170L/min for healthy young adult
Pulmonary function abnormalities can be
grouped into two main categories-
• Obstructive
• Restrictive
 Obstructive defects:
• Can occur in upper and larger airways or in smaller
airways(less than 2mm)
• Upper airways obstruction will reduce flow rates in the
initial 25% of a FVC maneuver
• Smaller airway obstruction will reduce flow rates in the
later portion of the exhaled volume
 Restrictive defects:
• Present when the lung volume are reduced to less
than 80% of the predicted levels
• Includes chest wall dysfunction, neurologic disorders,
scarring of lung, obesity
Pulmonary function testing
Pulmonary function testing
Pulmonary function testing
Measurement Obstructive Restrictive
FVC N or decrease Decrease
FEV1 Decrease Decrease
FEV1/FVC N or decrease N or increase
FEF25%-75% Decrease N or decrease
PEF Decrease N or decrease
FEF50 Decrease N or decrease
Slope of FV curve Decrease Increase
MVV Decrease N or decrease
Pulmonary function testing
Based on the initial results of a baseline spirometry,
additional testing of pulmonary mechanics is often
desirable.
If the baseline test indicates airway obstruction,
determining the reversibility of obstruction is
indicated.
In the laboratory , FVC maneuver is often repeated
after the patient has received a bronchodilator
Reversibility is defined as 15% or greater
improvement in FEV1
What is PFT & purpose of PFT.
Indications & contra-indication.
 lung volumes & capacities.
Flow – volume curve .
Classification : obstructive & restrictive.
Clinical interpretation.
1. WHAT IS PFT AND ITS PURPOSE? 5MARKS
2. WRITE THE INDICATION AND
CONTRAINDICATIONS OF THE PFT. 5MARKS
Pulmonary function testing

More Related Content

PPTX
Pulmonary Function Test's
PPTX
Pulmonary function test
PPT
Lung fuction tests
PPTX
Spirometry
PPT
Respiratory care
PPTX
Incentive Spirometry.pptx
PPTX
Pulmonary function test
PPTX
Equal pressure point
Pulmonary Function Test's
Pulmonary function test
Lung fuction tests
Spirometry
Respiratory care
Incentive Spirometry.pptx
Pulmonary function test
Equal pressure point

What's hot (20)

PPTX
Peep & cpap
PPTX
Humidification
PPTX
PPTX
PDF
Humidification Therapy
PPTX
Cardiopulmonary bypass
PPTX
Ventilator graphics
PPT
Aerosol therapy presentation
PPTX
Ventilation 7 patient-ventilator dyssynchrony
PPT
Respiratory Muscle Assessment
PPTX
Spirometry
PPTX
Extubation presentation
PPTX
Mechanical ventilation ppt
PPTX
Broncho hygienic techniques.
PPTX
PPT
Compliance Resistance & Work Of Breathing
PPTX
Pulmonary function tests
PPTX
PPTX
Respiratory failure
Peep & cpap
Humidification
Humidification Therapy
Cardiopulmonary bypass
Ventilator graphics
Aerosol therapy presentation
Ventilation 7 patient-ventilator dyssynchrony
Respiratory Muscle Assessment
Spirometry
Extubation presentation
Mechanical ventilation ppt
Broncho hygienic techniques.
Compliance Resistance & Work Of Breathing
Pulmonary function tests
Respiratory failure
Ad

Similar to Pulmonary function testing (20)

PPTX
lung volumes new v.pptx
PDF
pft6777777777777777777777hddgghjkkkk.pdf
PPTX
Lung volumes and capacities.pptx
PPTX
Pulmonary function tests
PPTX
Spirometry
PPTX
pulmonary function test
PDF
pulmonaryPFTfunc Tests.pdf
PDF
Pulmonary function test
PPTX
Pulmonary function tests
PPTX
Pulmonary function tests.pptx...........
PPT
Lung function tests
PPT
Pulmonary Function Tests Nonotes
PPTX
Pulmonary function test
PPTX
PULMONARY FUNCTION TEST (PFT)_ 082147.pptx
PPTX
Pft 10.12.14
PPTX
Pulmonary function tests
PPTX
Resp Physio and PFTmade by me welcome to
PPT
Information About Spirometry | Jindal Chest Clinic
PPTX
Pulmonary Function Test ppt
lung volumes new v.pptx
pft6777777777777777777777hddgghjkkkk.pdf
Lung volumes and capacities.pptx
Pulmonary function tests
Spirometry
pulmonary function test
pulmonaryPFTfunc Tests.pdf
Pulmonary function test
Pulmonary function tests
Pulmonary function tests.pptx...........
Lung function tests
Pulmonary Function Tests Nonotes
Pulmonary function test
PULMONARY FUNCTION TEST (PFT)_ 082147.pptx
Pft 10.12.14
Pulmonary function tests
Resp Physio and PFTmade by me welcome to
Information About Spirometry | Jindal Chest Clinic
Pulmonary Function Test ppt
Ad

More from Dr. Vitthalrao Vikhe Patil Foundation's College of Physiotherapy, Ahmednagar (20)

Recently uploaded (20)

PPTX
Important Obstetric Emergency that must be recognised
PPT
OPIOID ANALGESICS AND THEIR IMPLICATIONS
PDF
Khadir.pdf Acacia catechu drug Ayurvedic medicine
PPTX
JUVENILE NASOPHARYNGEAL ANGIOFIBROMA.pptx
PPT
Breast Cancer management for medicsl student.ppt
PPTX
Pathophysiology And Clinical Features Of Peripheral Nervous System .pptx
PPT
CHAPTER FIVE. '' Association in epidemiological studies and potential errors
PPTX
post stroke aphasia rehabilitation physician
PPTX
CME 2 Acute Chest Pain preentation for education
PPTX
POLYCYSTIC OVARIAN SYNDROME.pptx by Dr( med) Charles Amoateng
PPT
1b - INTRODUCTION TO EPIDEMIOLOGY (comm med).ppt
PPTX
Acid Base Disorders educational power point.pptx
PDF
Deadly Stampede at Yaounde’s Olembe Stadium Forensic.pdf
PPTX
Uterus anatomy embryology, and clinical aspects
PPT
ASRH Presentation for students and teachers 2770633.ppt
PPTX
Respiratory drugs, drugs acting on the respi system
PPTX
Chapter-1-The-Human-Body-Orientation-Edited-55-slides.pptx
PPTX
DENTAL CARIES FOR DENTISTRY STUDENT.pptx
PDF
NEET PG 2025 | 200 High-Yield Recall Topics Across All Subjects
PPT
Management of Acute Kidney Injury at LAUTECH
Important Obstetric Emergency that must be recognised
OPIOID ANALGESICS AND THEIR IMPLICATIONS
Khadir.pdf Acacia catechu drug Ayurvedic medicine
JUVENILE NASOPHARYNGEAL ANGIOFIBROMA.pptx
Breast Cancer management for medicsl student.ppt
Pathophysiology And Clinical Features Of Peripheral Nervous System .pptx
CHAPTER FIVE. '' Association in epidemiological studies and potential errors
post stroke aphasia rehabilitation physician
CME 2 Acute Chest Pain preentation for education
POLYCYSTIC OVARIAN SYNDROME.pptx by Dr( med) Charles Amoateng
1b - INTRODUCTION TO EPIDEMIOLOGY (comm med).ppt
Acid Base Disorders educational power point.pptx
Deadly Stampede at Yaounde’s Olembe Stadium Forensic.pdf
Uterus anatomy embryology, and clinical aspects
ASRH Presentation for students and teachers 2770633.ppt
Respiratory drugs, drugs acting on the respi system
Chapter-1-The-Human-Body-Orientation-Edited-55-slides.pptx
DENTAL CARIES FOR DENTISTRY STUDENT.pptx
NEET PG 2025 | 200 High-Yield Recall Topics Across All Subjects
Management of Acute Kidney Injury at LAUTECH

Pulmonary function testing

  • 1. Dr.Nidhi Ahya Assistant Professor Cardio-Vascular & Respiratory PTDVVPF College of Physiotherapy, Ahmednagar 414111
  • 2. Definition Purpose Indications & contra-indication  lung volumes & capacities Flow – volume curve Classification : obstructive & restrictive Clinical interpretation.
  • 3. Pulmonary function testing is the process of having the patient perform specific inspiratory and expiratory maneuvers while breathing in and out of tubing attached to the equipment that measure a variety of variables
  • 4. To determine the functional status of the lungs How much gas can be moved in and out of the lungs How fast gas can be moved The stiffness of the lung and chest wall The diffusion characteristics of the alveolar-capillary membrane How well lung responds to the therapy
  • 6. • To evaluate symptoms, signs or abnormal laboratory tests • To measure the effect of disease on pulmonary function • To differentiate between obstructive and restrictive disease • To screen individuals at risk of having pulmonary disease • To assess pre-operative risk • To assess prognosis, response to therapy
  • 7. • Hemoptysis of unknown origin • Pneumothorax • Unstable cardiovascular status or recent MI or pulmonary embolus • Thoracic, abdominal or cerebral aneurysms • Presence of an acute disease process that might interfere with test performance • Recent surgery of thorax and abdomen
  • 8. Nosocomial infection contracted from improperly cleaned tubing, mouthpiece
  • 9.  Height and weight: Taller person, larger lung size, and larger predicted lung volume Muscular person-increase in lung size Obese person-reduction in lung size  Gender: Males>females  Age: Vital capacity increases in person until mid 20s Average predicted VC for 20yrs is slightly over 5lt By age 70, approx 4lt Race Environmental factors Personal Factors
  • 11. Volume of air exhaled and inhaled during quiet breathing 350-600ml Decrease Vt can occur both in restrictive an obstructive defects
  • 12. The inspiratory reserve volume is the extra volume of air that can be inspired over and above the normal tidal volume when the person inspires forcefully.  It is usually equal to about 3000 ml
  • 13. The expiratory reserve volume is the maximum extra volume of air that can be expired by forceful expiration after the end of a normal tidal expiration  It normally amounts to about 1100 ml
  • 14. The residual volume is the volume of air remaining in the lungs after the most forceful expiration  This volume averages about 1200 Ml Is reduced in restrictive defects Increased in obstructive defects Expressed as ratio to TLC and VC
  • 17. The inspiratory capacity equals the tidal volume plus the inspiratory reserve volume. It’s the amount of air a person can breathe in, beginning at the normal expiratory level and distending the lungs to the maximum amount. about 3500 milliliters
  • 18.  The vital capacity equals the inspiratory reserve volume plus the tidal volume plus the expiratory reserve volume. This is the maximum amount of air a person can expel from the lungs after first filling the lungs to their maximum extent and then expiring to the maximum extent About 4600 ml If the person forcefully exhales the volume, it is called Forced vital capacity(FVC)
  • 19. Three phases of FVC maneuver: Maximal inspiratory effort Initial expiratory blast Forceful emptying of the lungs Both restrictive and obstructive defects can cause decrease in VC Important preoperative assessment factor useful in evaluating the patient’s need for mechanical ventilation
  • 20. FRC = ERV+RV Resting volume of the lungs after exhalation of Vt breath This is the amount of air that remains in the lungs at the end of normal expiration About 2300 ml Represents balance between the expanding chest wall forces and the contractile rebound forces of lung tissue
  • 21. Sum of VC and RV Is increased with most obstructive lung defects and decreased with restrictive lung defects To measure TLC, RV must be determined
  • 22. The lung volumes that can be directly measured using a spirometer include- Tidal Volume, Inspiratory Reserve Volume, Expiratory Reserve Volume and thus Vital Capacity Total Lung Capacity can be measured if RV and FRC are known. RV and FRC is obtained in one of indirect methods: Body plethysmograph (body box) Open-circuit nitrogen washout Closed-circuit helium dilution
  • 23. Generated by integrating flow with volume on graph Volume is plotted on the horizontal axis Flow on the vertical axis Expiratory loop is shown above the line
  • 24. Generated by integrating volume with time on graph Volume is plotted on the vertical axis Time on the horizontal axis Volume – Liters Time- secs
  • 25. The expiratory side of the FVC curve provides data regarding the contractile state of the airways This part of the curve evaluates the amount of the obstruction present in the patient’s airways Routinely identified flows are: FEV1 --FEV25%-75% FEV3 --PEF
  • 26. Measures the maximal volume of air exhaled during the first second of expiration Reflects the flow characteristics in the larger airways Best indicator of obstructive diseases Expressed as percentage of the observed FVC (FEV1/FVC) Normal: 75% of VC in 1 second Decreased: acute and chronic obstructive pulmonary disease Normal in restrictive disorders
  • 27. Look at the 3-second point of the expired curve Indication of the flow in smaller airways Decrease normally with age Normal: approx 95%
  • 28. FEV25%-75% Expressed in liters/second Indicator of flow First 25% is disregarded because of the lung’s initial inertia Last 25% is disregarded because of effort dependency Middle 50% reflects the degree of airway patency Early indicator of obstructive disease Can also be reduced in restrictive dysfunction
  • 29. Is the maximum flow rate achieved by the patient during the FVC maneuver PEF < 100L/min : severe obstructive disease PEF= 100 to 200L/min : moderate obstructive disease PEF > 200L/min : mild obstructive disease
  • 30. Indicates the respiratory muscle endurance Requires the patient to inhale and exhale as quickly as possible for a period of 12 secs Normal: 170L/min for healthy young adult
  • 31. Pulmonary function abnormalities can be grouped into two main categories- • Obstructive • Restrictive
  • 32.  Obstructive defects: • Can occur in upper and larger airways or in smaller airways(less than 2mm) • Upper airways obstruction will reduce flow rates in the initial 25% of a FVC maneuver • Smaller airway obstruction will reduce flow rates in the later portion of the exhaled volume  Restrictive defects: • Present when the lung volume are reduced to less than 80% of the predicted levels • Includes chest wall dysfunction, neurologic disorders, scarring of lung, obesity
  • 36. Measurement Obstructive Restrictive FVC N or decrease Decrease FEV1 Decrease Decrease FEV1/FVC N or decrease N or increase FEF25%-75% Decrease N or decrease PEF Decrease N or decrease FEF50 Decrease N or decrease Slope of FV curve Decrease Increase MVV Decrease N or decrease
  • 38. Based on the initial results of a baseline spirometry, additional testing of pulmonary mechanics is often desirable. If the baseline test indicates airway obstruction, determining the reversibility of obstruction is indicated. In the laboratory , FVC maneuver is often repeated after the patient has received a bronchodilator Reversibility is defined as 15% or greater improvement in FEV1
  • 39. What is PFT & purpose of PFT. Indications & contra-indication.  lung volumes & capacities. Flow – volume curve . Classification : obstructive & restrictive. Clinical interpretation.
  • 40. 1. WHAT IS PFT AND ITS PURPOSE? 5MARKS 2. WRITE THE INDICATION AND CONTRAINDICATIONS OF THE PFT. 5MARKS